Konstantin Viktorovich Lyadov

Konstantin Viktorovich Lyadov

Auto-generated profile, based on publicly available information

Konstantin Viktorovich Lyadov

Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Problems of Balneology, Physiotherapy and Exercise Therapy
Verified
Journal Article
Closed access
GDG.V. Derevyashkina
G.V. Derevyashkina
EKE.S. Koneva
E.S. Koneva
TST.V. Shapovalenko
T.V. Shapovalenko
DBD.R. Bisheva
D.R. Bisheva
ISI.V. Sidyakina
I.V. Sidyakina
KLK.V. Lyadov
K.V. Lyadov
To analyze the effectiveness of social recovery (trip to the store by bus and making purchases) in elderly patients with stroke in the right middle cerebral artery undergoing a course of specialized trainings in a complex of functional spatially oriented rehabilitation. The study involved 44 patients with previous stroke (mean age 70.8±3.1 years) randomized into 2 equal groups: main group - basic standard of rehabilitation (exercises with instructor, mechanotherapeutic technique with cyclic simulators, massage of paretic limbs) and training of social adaptation in a complex of functional spatially oriented rehabilitation; control group - basic standard of rehabilitation alone. Duration of rehabilitation course was 14 days. To determine mean norm of timing of complex training of socially significant skill, we asked 23 volunteers without severe comorbidities to perform tasks of functional spatially oriented rehabilitation. After complex rehabilitation program, we found significant dynamics of time necessary for the following actions: "take a bag and hang it over shoulder", "open the pockets of the bag with a zipper (2 pockets)", "take the jacket off the hanger and put it on", "take the products from the basket and put in the pocket". Moreover, the main group was characterized by significantly lower impairment of daily activity (Barthel score 66.3±4.5 vs. baseline 45.7±4.9, p0.05). These values turned out to be significantly better than in the control group. These results indicate the effectiveness of functional spatially oriented rehabilitation in elderly patients with cerebral stroke. This approach increases personal independence in daily life and improves overall quality of life.

24 April 2023 in Problems of Balneology, Physiotherapy and Exercise Therapy
Verified
Journal Article
Closed access
LLL.D. Litvina
L.D. Litvina
SKS.M. Konev
S.M. Konev
EKE.S. Koneva
E.S. Koneva
ДБДмитрий Бутко
Дмитрий Бутко
KLK.V. Lyadov
K.V. Lyadov
KKK.V. Kotenko
K.V. Kotenko
INTRODUCTION As a prevention of falls in elderly people with chronic cerebral ischemia, it is necessary to carry out rehabilitation measures with the inclusion of training aimed at improving statolocomotor and cognitive functions, improving proprioceptive sensitivity and reaction speed to external stimuli. AIMS To compare the effectiveness of inclusion of hardware balance training on Huber («LPG-Systems», France) and C-mill («Physiomed Elektromedizin AG», Germany) simulators in complex postural control rehabilitation programs for elderly patients with chronic cerebral ischemia (CCI). MATERIAL AND METHODS The study included 48 patients (19 men, 29 women), 81% of whom had moderate cognitive impairment. The median age was 76.2±8.5 years. The median Morse scale score before rehabilitation was 50.2 (CI 74—80). The patients were divided into three groups by randomization method: the patients of the 1st comparison group (n=16) were assigned to the Huber stabilizer; the patients of the 2nd comparison group (n=16) underwent training on the track with BOS-video reconstruction of walking «C-mill»; the patients of the control group (n=16) underwent the course of therapeutic gymnastics according to the developed method. The duration of the course in each group amounted to 8 therapeutic procedures. In the dynamics of the conducted trainings we evaluated: the risk of falls, parameters of postural disorders in statics and dynamics, as well as criteria determining cognitive dysfunction and quality of life of patients. RESULTS A pronounced improvement of static and dynamic postural indices was observed in the first comparison group, where there was a significant improvement of stabilometric indices: «SL» (p=0.001), amplitude of saggital sway (p=0.014), walking speed (p=0.001) and percentage of hitting the marks (p=0.001). The second comparison group showed significant improvement in dynamic balance parameters: walking speed (p=0.001), stride width (p=0.006), percentage of hitting the marks (p=0.001). CONCLUSION Training on rehabilitation simulators according to the applied methods contributed to the improvement of fall risk related indicators as well as the effectiveness of improving motor performance in older adults with HIM compared to the control group. However, training on the stable-platform induced more significant clinical effects on both static and dynamic balance.

18 January 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
MLM. A. Lyadova
M. A. Lyadova
EDE. A. Denisova
E. A. Denisova
DFDenis Fedorinov
Denis Fedorinov
YEYu. S. Esakov
Yu. S. Esakov
AOAleksandra Sergeevna Orlova
Aleksandra Sergeevna Orlova
VGV. N. Galkin
V. N. Galkin
Introduction. Non-small cell lung cancer (NSCLC) is a form of lung cancer with high incidence and low overall survival. Immunotherapy is a promising treatment method for which the selection of optimal treatment regimens for each individual patient is important.Aim. To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICIs) in patients with advanced NSCLC.Materials and methods. The study included 247 patients (190 men and 57 women) aged 37 to 87 years who received ICIs as monotherapy with nivolumab (n = 58; 23.4%), pembrolizumab (n = 78; 31.6%) and atezolizumab (n = 13; 5.3%), and in the form of combination chemoimmune therapy (n = 98; 39.7%). The objective response of the tumor to treatment was recorded in the presence of partial or complete regression of the tumor. The tumor response to treatment was determined in accordance with the iRECIST criteria.Results. Objective response was achieved in 20.6% of patients, of which 13.7% were on the first line setting, and 7% of patients were on the 2nd or more line setting. Disease control was recorded in 83.3% of patients. Patients receiving combination chemoimmune therapy had a better response to treatment than those receiving monotherapy (χ2 = 9.309; p = 0.020). Grade 3–4 immuno-related adverse events were observed only in 5 (2.02%) patients.Conclusions. NSCLC immunotherapy allows to achieve high rates of objective response and disease control (20.6 and 83.3%, respectively), with a small number of grade 3–4 immuno-related adverse events (2.02% according to our data), which indicates an acceptable safety profile.

5 June 2026 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
ДБДмитрий Бутко
Дмитрий Бутко
ADA.T. Davydov
A.T. Davydov
EKE.S. Koneva
E.S. Koneva
KLK.V. Lyadov
K.V. Lyadov
AOA.A. Okhotnikova
A.A. Okhotnikova
EYE.V. Yakovlev
E.V. Yakovlev
Objective. To conduct a comparative analysis of the effectiveness of combined neuroprotection in conjunction with high-intensity magnetic therapy for patients with ischemic stroke in the vertebrobasilar system. Material and methods. This clinical study was a multicenter, prospective, observational, comparative, parallel-group study conducted in both public and private clinics as well as in rehabilitation facilities in St. Petersburg and Moscow. The study enrolled 98 participants, comprising 59 women and 39 men, aged 40 to 68 years (mean age: 54±1.5 years). Participants were randomized into three groups, each receiving standard therapy comprising exercise therapy, massage, and physiotherapy, as per established clinical guidelines. Group I (n=34) also received Cortexin at a dosage of 10 mg intramuscularly twice daily for 15 days, and Recognan oral solution at 1000 mg, 10 ml, once daily for 21 days, along with high-intensity magnetic muscle stimulation. Participants in Group II (n=33) received Cortexin at the same dosage and schedule, coupled with high-intensity magnetic muscle stimulation. Group III (n=31) received no additional treatment. Treatment effectiveness was evaluated based on clinical and neurological metrics, cognitive function assessments, electroencephalography data, ultrasound dopplerography (USDG) of cervical and cranial vessels, and neuropsychological testing administered on days 14 and 21 post-onset of the stroke. Results. In Group I, a 27% reduction in lower limb spasticity was noted on day 14, whereas Group II exhibited a 25% reduction, with Group III demonstrating a 15% reduction. USDG data indicated that 52% of patients in Group I showed increases in maximum and linear blood flow velocity in both the right and left vertebral arteries after treatment, compared to 41% in Group II and 20% in Group III. The mean score on the NIH Stroke Scale for Group I patients at discharge was 9.3±0.2 points, and the Rankin scale score was 2.1±0.2 points. Conclusion. The findings suggest that a multimodal approach to restorative treatment, combining neuroprotective medications with high-intensity magnetic therapy, demonstrates considerable therapeutic efficacy in the medical rehabilitation of patients with ischemic stroke.

10 April 2025 in Fizioterapevt (Physiotherapist)
Verified
Journal Article
Closed access
AKA. A. Kostenko
A. A. Kostenko
EKE. S. Koneva
E. S. Koneva
EZE. N. Zhumanova
E. N. Zhumanova
ATA. V. Tsvetkova
A. V. Tsvetkova
KLK. V. Lyadov
K. V. Lyadov
Objective: To analyze the effectiveness and safety of interval hypoxic-hyperoxic therapy (IHHT) in the framework of complex rehabilitation programs for patients who have had pneumonia associated with COVID-19. Material and methods. The study included 48 patients divided into two groups: the first group (n = 24) received a standard rehabilitation course, including therapeutic exercises, therapeutic massage, physiotherapy procedures, in the second group of patients (n = 24), IHHT procedures on the ReOxy device were included in the complex rehabilitation course. Physical endurance (sit-stand test), psychoemotional state of patients (HADS, IZHU tests), laboratory parameters (hemoglobin, red blood cell count, C-reactive protein) and oxygenation parameters were assessed. Results. The second group of patients demonstrated a statistically significant improvement in exercise tolerance (p < 0.05). Mild pneumonia (lung CT stage 1–2) was associated with higher blood hemoglobin levels after completion of the rehabilitation course (128.3±6.4 g/l vs. 121.3±9.3 g/l; p=0.075), erythrocytes (4.4±0.2 ×10¹²/l vs. 4.0±0.3 ×10¹²/l; p=0.025) and lower CRP levels (11.1±11.7 mg/l vs. 18.7±10.5 mg/l; p=0.036). Hypoxicyperoxy therapy contributed to an increase in hemoglobin in patients with lung CT stage 1–2 by 9.4 g/l (p=0.03). Conclusions. Comprehensive rehabilitation programs have shown effectiveness in patients with the consequences of COVID-associated pneumonia with mild to moderate lung damage (lung CT 1-2st). In addition, it was found that the inclusion of IHGT procedures in comprehensive rehabilitation is safe and effective in increasing exercise tolerance.

30 August 2024 in Consilium Medicum
Verified
Journal Article
Open access
PDF file
MLMarina A. Lyadova
Marina A. Lyadova
DFDenis Fedorinov
Denis Fedorinov
JMJulia S. Mansurova
Julia S. Mansurova
EKEvgeniya S. Kuzmina
Evgeniya S. Kuzmina
YEYury S. Esakov
Yury S. Esakov
IPIrina V. Poddubnaya
Irina V. Poddubnaya
Background. Small cell lung cancer (SCLC), predominantly due to smoking, is a highly differentiated, rapidly growing epithelial cell carcinoma of high malignancy originating from bronchial neuroendocrine cells. Almost 70% of SCLC patients have metastases at the time of diagnosis, which requires the use of drug therapies, including immunotherapy. Aim. To evaluate the efficacy and safety of immune checkpoint inhibitors in patients with small cell lung cancer. Materials and methods. One hundred and twenty one patients (90 men and 31 women) aged 44 to 84 years were included in the retrospective multicentre non-randomised study. The majority (90.9%) of patients were treated in the 1st line of therapy. IT were administered in the 2nd line and subsequent lines of treatment in 9.1% of patients. Weakened (ECOG 2–3) state at the time of treatment initiation was noted in 30 (24.8%) patients. Results. Progression-free survival in patients with SCLC receiving 1st-line treatment was 5.82 (95% CI 3.92–7.72) months, and 2nd-line and beyond was 6.21 (95% CI 0.76–11.66) months. Survival in patients with small-cell lung cancer receiving 1st-line IT was 8.0 (95% CI 6.18–9.81) months, and 2nd-line or longer was 11.3 months (95% CI 4.31–18.29) months (p=0.108). Objective response was achieved in 43 (35.5%) patients, of whom 38 (34.5%) were on first-line IT and 5 (45.5%) patients were on 2nd or more. iAEs grade 3–4 was observed in only 18 (14.9%) patients. Conclusion. Immunotherapy for SCLC allows achieving high rates of objective response and disease control. This method of treatment is characterized by insignificant number of grade 3–4 immune-mediated adverse events, which indicates an acceptable safety profile.